Biogen Pharmachem Industries Limited reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported negative revenue was INR 15.37 million compared to revenue of INR 12.52 million a year ago. Net loss was INR 15.9 million compared to net income of INR 2.01 million a year ago. Basic loss per share from continuing operations was INR 0.02. Diluted loss per share from continuing operations was INR 0.02.